UNASSIGNED: This review covers all the major nanotechnology-based patent litrature available on renowned patent data bases like Patentscope and Espacenet, through the time period of 2007-2022. This is an entirely patent centric review, and it includes both clinical and non-clinical data available on nanotechnology-based therapeutics and diagnostic tools for pancreatic cancer.
UNASSIGNED: For the sake of understanding, the patents are categorized under various formulation-specific heads like metallic/non-metallic nanoparticles, polymeric nanoparticles, liposomes, carbon nanotubes, protein nanoparticles and liposomes. This distinguishes one specific nanoparticle type from another and makes this review a one-of-a-kind comprehensive patent compilation that has not been reported so far in the history of nanotechnological formulations in pancreatic cancer.
■这篇综述涵盖了在著名专利数据库(如Patentscope和Espacenet)上提供的所有主要的基于纳米技术的专利文献,在2007-2022年期间。这是一个完全以专利为中心的综述,它包括基于纳米技术的胰腺癌治疗和诊断工具的临床和非临床数据。
■为了理解,这些专利被归类为各种配方特定的头部,如金属/非金属纳米颗粒,聚合物纳米颗粒,脂质体,碳纳米管,蛋白质纳米颗粒和脂质体。这将一种特定的纳米颗粒类型与另一种纳米颗粒类型区分开来,并使这篇综述成为一种综合专利汇编,迄今为止,在胰腺癌纳米技术制剂的历史上尚未报道。